Advertisement

Prostaglandins and their Inhibitors in Clinical Obstetrics and Gynaecology

  • Marc Bygdeman
  • Gary S. Berger
  • Louis G. Keith
Book

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Basic Science

    1. Front Matter
      Pages 1-1
    2. F. A. Kimball, K. T. Kirton
      Pages 3-12
  3. Reproductive Physiology

    1. Front Matter
      Pages 27-27
    2. U. Ulmsten
      Pages 29-57
    3. V. Lundström
      Pages 59-81
    4. B. Lindblom
      Pages 83-98
    5. L. Hamberger, P. O. Janson, L. Nilsson
      Pages 99-108
    6. N. L. Poyser
      Pages 109-130
    7. M. Bygdeman
      Pages 131-142
  4. Clinical Applications

    1. Front Matter
      Pages 143-143
    2. A. A. Calder
      Pages 145-164
    3. A. P. Lange
      Pages 165-202
    4. M. Thiery, J. J. Amy
      Pages 203-231
    5. M. K. Toppozada
      Pages 233-251
    6. S. S. Ratnam, R. N. V. Prasad
      Pages 253-270
    7. N. H. Lauersen
      Pages 271-314
    8. P. T. Russell, O. M. Owens
      Pages 315-334
  5. Future Applications

    1. Front Matter
      Pages 335-335
    2. F. Broughton Pipkin, E. M. Symonds
      Pages 337-366
    3. P. W. Budoff
      Pages 367-389
    4. E. L. Marut
      Pages 391-409
    5. G. S. Berger, M. Bygdeman, L. G. Keith
      Pages 411-419
  6. Back Matter
    Pages 421-430

About this book

Introduction

It is clear today that several prostaglandins play an important role in the regulation of many of the physiological events of the reproductive organs in the human. Both naturally occurring prostaglandins and their analogues are used routinely in many countries to ripen the cervix and induce labour at term as well as to dilate the cervix and to terminate pregnancy. Prostaglandin biosynthesis inhibitors are widely used in the treatment of primary dysmenorrhoea. The editors have aimed at an accurate, thorough, yet easily under­ standable review of the status in 1986 of medical knowledge regarding both the physiological importance and the clinical use of prostaglan­ dins and their inhibitors in obstetrics and gynaecology. I believe this book will be of value for all clinicians concerned with reproductive health. The list of authors guarantees an authoritative and up-to-date review of this active field. SUNE BERGSTROM Karolinska Institutet, Stockholm, Sweden Table Examples of clinical use of natural prostaglandins and some prostaglandin analogues Indications Prostaglandin Route of administration Manufacturer Dilatation of the cervix prior 15-methyl-PGF • Intramuscular Upjohn, USA 2 to vacuum aspiration 16-phenoxy-PGE methyl sulphonylamide Intramuscular Schering AG, West Germany 2 16,16-dimethyl-PGE methyl ester 1 Vaginal ONO, Japan; May & Baker, UK Second trimester abortion Intra -amniotic Upjohn, USA; ONO, Japan PGF 20 Upjohn, USA PGE Vaginal 2 Upjohn, USA 15-methyl-PGF 2.

Keywords

ecology obstetrics

Editors and affiliations

  • Marc Bygdeman
    • 1
  • Gary S. Berger
    • 2
  • Louis G. Keith
    • 3
  1. 1.Department of Obstetrics and GynecologyKarolinska Hospital01 StockholmSweden
  2. 2.Chapel Hill Fertility ServicesChapel HillUSA
  3. 3.Department of Obstetrics and GynecologyNorthwestern University Medical SchoolChicagoUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-94-011-6734-5
  • Copyright Information Springer Science+Business Media B.V. 1986
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-94-011-6736-9
  • Online ISBN 978-94-011-6734-5
  • Buy this book on publisher's site
Industry Sectors
Biotechnology